Company profile: Cephea
1.1 - Company Overview
Company description
- Provider of catheter-delivered mitral valve regurgitation products and heart valves for the treatment of coronary artery disease, offering catheter-based therapies including balloons and stents for aortic valve replacements. Incorporated in 2011 and based in San Jose, California.
Products and services
- Aortic Valve Replacement Balloons: Catheter-based components for aortic valve replacements, engineered as balloon devices used within catheter therapies during aortic valve replacement procedures in patients
- Aortic Valve Replacement Stents: Catheter-based components for aortic valve replacements, built as stent devices used within catheter therapies during aortic valve replacement procedures in patients
- Catheter-Delivered Mitral Valve Regurgitation Heart Valves: Catheter-based heart valve assemblies that treat mitral valve regurgitation in patients, engineered for catheter delivery to the mitral position during treatment procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cephea
Currie Medical
HQ: United States
Website
- Description: Provider of pneumatic compression devices and garments for DVT prevention, including the ALP DVT Prevention System and VasQcare home-based DVT/PE therapy; ReCur reprocessing services for collection of single-use devices; fluid warming drapes and systems; biohazard spill kits; and medical waste solidifiers to support safety, cost savings, and environmental impact reduction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Currie Medical company profile →
Apica Cardiovascular
HQ: Ireland
Website
- Description: Provider of cardiovascular device technology for access and closure of the heart’s apex and peripheral vascular system, with applications in Transcatheter Heart Valves (TAVI), AAA, and LVAD implantation; pre-revenue medical device company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apica Cardiovascular company profile →
Positron
HQ: United States
Website
- Description: Provider of full nuclear cardiology solutions as a research and development company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Positron company profile →
Myogen
HQ: United States
Website
- Description: Provider of small molecule therapeutics for cardiovascular disorders, focused on the discovery, development and commercialization of treatments, combining advanced understanding of cardiovascular disease biology with clinical development expertise in cardiovascular therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myogen company profile →
Celladon
HQ: United States
Website
- Description: Provider of biotechnology focused on developing molecular therapies for the treatment of heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celladon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cephea
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cephea
2.2 - Growth funds investing in similar companies to Cephea
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cephea
4.2 - Public trading comparable groups for Cephea
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →